Associate Surgeon, Brigham and Women's Hospital Assistant Professor, Harvard Medical School Fellow, Pandolfi Cancer Genetics Program

Breast Surgery

Doctor Daniel T. Ruan, MD works in the field of Breast Surgery . He went to medical school at Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received awards:"Fellow" and "Most Compassionate Doctor". Daniel T. Ruan, MD is a published physician. He has 43 publications published. The most current publication "Bethesda Categorization of Thyroid Nodule Cytology & Prediction of Thyroid Cancer Type and Prognosis." Doctor Daniel T. Ruan, MD accepts all Medicare patients.

Publications

---

• Bethesda Categorization of Thyroid Nodule Cytology & Prediction of Thyroid Cancer Type and Prognosis.
• False negative cytology in large Thyroid nodules.
• Hypoglycemia after resection of pheochromocytoma.
• Pheochromocytoma: A Devious Opponent in a Game of Hide-and-Seek.
• Influence of particle size and calcium source on production performance, egg quality, and bone parameters in laying ducks.
• Adrenocortical carcinoma: The management of metastatic disease.
• Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and Parathyroid hormone.
• Solid Adrenal mass: not always what it seems.
• CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens.
• Surgeons and Patients Disagreeon the Potential Consequences from HypoParathyroidism.
• A multi-institutional international study of risk factors for hematoma after Thyroidectomy.
• Bilateral Neck Exploration Decreases Operative Time Compared to Minimally Invasive Parathyroidectomy in Patients with Discordant Imaging.
• Thyroid nodule size and prediction of Cancer.
• Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of a sequential management strategy.
• Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive Cancers.
• Primary Hyperparathyroidism and FHH: Relationships and Clinical Implications.
• Thyroid-specific knockout of the Tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-...
• Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical Cancers.
• Preoperative basal calcitonin and Tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thy...
• Critical role of identification of the second Gland during unilateral parathyroid surgery: a prospective review of 119 patients with concordant localization.
• Minimally invasive Adrenal surgery: an update.
• Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid Cancer.
• Metastatic papillary thyroid Cancer misdiagnosed as small cell lung Cancer.
• Giant Pancreatic Tumor with Clinical Characteristics of Insulinoma but without Common Pathologic Features.
• Adrenal artery aneurysm encountered during laparoscopic Adrenalectomy for pheochromocytoma.
• Prospective evaluation of the rate and impact of hemolysis on intraoperative Parathyroid hormone (IOPTH) assay results.
• Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid Cancer.
• Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid Cancer cells with the BRAFV600E mutation.
• Patterns of antibiotic prophylaxis use for thyroidectomy and Parathyroidectomy: results of an international survey of endocrine surgeons.
• Surgery and staging of pancreatic Neuroendocrine tumors: a 14-year experience.
• Autophagy: a new target for advanced papillary thyroid Cancer therapy.
• Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid Cancer.
• Should all duty hours be the same? Results of a national survey of surgical trainees.
• Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid Cancer cells.
• Hemolysis falsely decreases intraoperative Parathyroid hormone levels.
• Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid Cancers.
• Surgery for Hyperparathyroidism in image-negative patients.
• Pneumatosis intestinalis and portal venous gas without bowel ischemia in a patient treated with irinotecan and cisplatin.
• Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorect...
• Liver-directed therapies in colorectal Cancer.
• Palliative techniques for hepatic Cancer.
• Bronchogenic cyst masquerading as an Adrenal tumor: a case of mistaken identity.

Schools

---

• Duke University School Of Medicine

• University Of California San F

Procedures Preformed

---

• Adrenalectomy
• Minimally Invasive Surgery
• ParaThyroidectomy
• Thyroid Surgery
• View All

Conditions Treated

---

• Adrenal Gland Cancer
• HyperparaThyroidism
• Neuroendocrine Tumors
• ParaThyroid (Gland) Tumor: Other than Malignant
• View All

Doctors Specialties

---

• Endocrine Surgery
• General Surgery

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Assurant Health
• Blue Card PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access
• First Health (Coventry Health Care)
• Guardian
• Harvard Pilgrim Health Care PPO
• Choice Care PPO
• MultiPlan PPO
• PHCS Network PPO
• Tufts PPO
• Choice Plus POS
• Options PPO

Awards

---

• Fellow
• Most Compassionate Doctor

Education

---

• UCSF
• Brigham and Women's Hospital
• Duke University School of Medicine

Hospital

---

• Massachusetts General Hospital
• Dana-Farber Cancer Institute
• Brigham and Women's Hospital

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1285711275
Last Name Of The Provider	RUAN
First Name Of The Provider	DANIEL
View All

Similar Doctors

---

	Dr. Scheuster E. Christie, MD This Doctor is OpenDoctor Recommended.
	Dr. Kimberly A. Caprio, MD This Doctor is OpenDoctor Recommended.
	Dr. VanEssa Carolina Tang-Fernandez, MD This Doctor is OpenDoctor Recommended.
	Dr. Solomon Mojtabai, MD
	Dr. Hormuzdiyar H. Dasenbrock, MD This Doctor is OpenDoctor Recommended.
	Dr. Leigh A. Compton, MD
	Dr. Alexandra Briggs, MD This Doctor is OpenDoctor Recommended.
	Dr. Aferdita Spahillari, MD
	Dr. Suzanne N. Coopey, MD This Doctor is OpenDoctor Recommended.
	Dr. Henrik Malchau, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James C. Cusack Jr., MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Limaris Barrios, MD This Doctor is OpenDoctor Recommended.
	Dr. Douglas S. Smink, MD This Doctor is OpenDoctor Recommended.
	Dr. Roy Phitayakorn, MD This Doctor is OpenDoctor Recommended.
	Dr. Omar Y. Kudsi, MD This Doctor is OpenDoctor Recommended.
	Dr. Rathi Asaithambi, MD
	Dr. Anjali A. Verghese, MD This Doctor is OpenDoctor Recommended.
	Dr. Ehsan Chitsaz, MD This Doctor is OpenDoctor Recommended.
	Dr. Juan Rodolfo Mella-Catinchi, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog